Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference

Hepatology

Volumn 50, Issue 1, 2009, Pages 46-55

  Bellecave, Pantxika ^a   Gouttenoire, Jérôme ^a   Gajer, Markus ^b   Brass, Volker ^b   Koutsoudakis, George ^c   Blum, Hubert E ^b   Bartenschlager, Ralf ^c   Nassal, Michael ^b   Moradpour, Darius ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; MIXED INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REPLICON; SUPERINFECTION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS INTERFERENCE; VIRUS REPLICATION; CELL CULTURE; VIROLOGY;

CELLS, CULTURED; HEPATITIS B; HEPATITIS C; HUMANS; VIRAL INTERFERENCE;

EID: 67651148539     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22951     Document Type: Article

References (36)

1. Alberti A, Pontisso P, Chemello L, Fattovich G, Benvegnu L, Belussi F, et al. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol 1995;22:38-41.
2. Raimondo G, Saitta C. Treatment of the hepatitis B virus and hepatitis C virus co-infection: still a challenge for the hepatologist. J Hepatol 2008;49:677-679.
3. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006;368:938-945. (Pubitemid 44331386)
4. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004;126:1024-1029. (Pubitemid 38451174)
5. Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, et al. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. HEPATOLOGY 2002;36:1285-1291. (Pubitemid 35253448)
6. Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J, et al. The HEP-NET B/C co-infection trial: a prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection. J Hepatol 2008;49:688-694.
7. Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, et al. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 2008;136:496-504.
8. Chen SY, Kao CF, Chen CM, Shih CM, Hsu MJ, Chao CH, et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003;278:591-607. (Pubitemid 36043613)
9. Pasquinelli C, Shoenberger JM, Chung J, Chang K-M, Guidotti LC, Selby M, et al. Hepatitis C virus core and E2 protein expression in transgenic mice. HEPATOLOGY 1997;25:719-727. (Pubitemid 27106460)
10. Pan Y, Wei W, Kang L, Wang Z, Fang J, Zhu Y, et al. NS5A protein of HCV enhances HBV replication and resistance to interferon response. Biochem Biophys Res Commun 2007;359:70-75.
11. Guo H, Zhou T, Jiang D, Cuconati A, Xiao GH, Block TM, et al. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J Virol 2007;81:10072-10080. (Pubitemid 350067711)
12. Sun D, Nassal M. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol 2006;45:636-645. (Pubitemid 44466664)
13. Moradpour D, Evans MJ, Gosert R, Yuan ZH, Blum HE, Goff SP, et al. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol 2004;78:7400-7409. (Pubitemid 38915885)
14. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 2006;103:7408-7413. (Pubitemid 43727846)
15. Sällberg M, Ruden U, Magnius LO, Harthus HP, Noah M, Wahren B. Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen. J Med Virol 1991;33:248-252.
16. Moradpour D, Englert C, Wakita T, Wands JR. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 1996;222:51-63.
17. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992;89:5547-5551.
18. Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990;249:912-915. (Pubitemid 20268298)
19. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002;76:13001-13014.
20. Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL, Liu CC, et al. Complete replication of hepatitis C virus in cell culture. Science 2005;309:623-626. (Pubitemid 41033648)
21. Gosert R, Egger D, Lohmann V, Bartenschlager R, Blum HE, Bienz K, et al. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J Virol 2003;77:5487-5492. (Pubitemid 36460961)
22. Christen V, Duong F, Bernsmeier C, Sun D, Nassal M, Heim MH. Inhibition of alpha interferon signaling by hepatitis B virus. J Virol 2007;81:159-165. (Pubitemid 44975156)
23. Frese M, Pietschmann T, Moradpour D, Haller O, Bartenschlager R. Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 2001;82:723-733. (Pubitemid 32280029)
24. Rang A, Will H. The tetracycline-responsive promoter contains functional interferon-inducible response elements. Nucleic Acids Res 2000;28:1120-1125. (Pubitemid 30107680)
25. Lohmann V, Hoffmann S, Herian U, Penin F, Bartenschlager R. Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 2003;77:3007-3019. (Pubitemid 36228086)
26. Huang ZM, Tan T, Yoshida H, Mori K, Ma Y, Yen TS. Activation of hepatitis B virus S promoter by a cell type-restricted IRE1-dependent pathway induced by endoplasmic reticulum stress. Mol Cell Biol 2005;25:7522-7533. (Pubitemid 41170115)
27. Kim J, Choi TG, Ding Y, Kim Y, Ha KS, Lee KH, et al. Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress. J Cell Sci 2008;121:3636-3648.
28. Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. HEPATOLOGY 2006;43:100-107. (Pubitemid 43733596)
29. Rodriguez-Inigo E, Bartolome J, Ortiz-Movilla N, Platero C, Lopez-Alcorocho JM, Pardo M, et al. Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection. J Virol 2005;79:15578-15581. (Pubitemid 43032340)
30. Lee YM, Tscherne DM, Yun SI, Frolov I, Rice CM. Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication. J Virol 2005;79:3231-3242. (Pubitemid 40330934)
31. Schaller T, Appel N, Koutsoudakis G, Kallis S, Lohmann V, Pietschmann T, et al. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 2007;81:4591-4603. (Pubitemid 46668657)
32. Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, McKeating JA, et al. Superinfection exclusion in cells infected with hepatitis C virus. J Virol 2007;81:3693-3703. (Pubitemid 46586866)
33. Walters KA, Joyce MA, Addison WR, Fischer KP, Tyrrell DL. Super-infection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen. J Virol 2004;78:7925-7937.
34. Köck J, Nassal M, MacNelly S, Baumert TF, Blum HE, von Weizsäcker F. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 2001;75:5084-5089. (Pubitemid 32448530)
35. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 2002;99:15655-15660. (Pubitemid 35403987)
36. Jo J, Aichele U, Kersting N, Klein R, Aichele P, Bisse E, et al. Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology 2009. In press.